A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Financial Summary
| Share Statistics | IVF | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.7 | $334.8 | 1% |
|
| Shares Out (Mil) | 1.6 | 41.7 | 6% |
|
| Institutional Ownership | 100.0% | 77.3% | 99% |
|
| Float (Mil) | 1.8 | 34.7 | 5% |
|
| Beta | na | 0.86 | na |
|
| Avg Daily Volume (000s) | 99 | 266 | 36% |
|
| Price Change (52-week) |
(98.7%) | 60.7% | 1% |
|
| Growth | IVF | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 10.7% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($5.600) | ($23.200) | ($8.000) | |
| Month Ago EPS | ($5.600) | ($23.200) | ($8.000) | |
| # Rev Up | na | 1 | 1 | |
| # Rev Down | na | 0 | 0 | |
| Three Months Ago EPS | ($5.600) | ($23.200) | ($8.000) | |
| Year/Year Chg | 65.6% | (62.0%) | (104.6%) | |
| Financials | IVF | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $7 | $152 | 7% |
|
| Net Income (TTM) (Mil) | ($12) | ($11) | 28% |
|
| EPS (TTM) | ($25.254) | ($0.500) | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($5) | ($2) | 24% |
|
| Net Cash Flow (TTM) (Mil) | $4 | $1 | 52% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $22 | 21% |
|
| Enterprise Value (Q1) (Mil) | $1 | $304 | 4% |
|
| Valuation | IVF | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.10 | 2.88 | 1% |
|
| P/E | na | 30.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | IVF | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 36.9% | 59.1% | 45% |
|
| Net Margin | (158.7%) | (7.7%) | 6% |
|
| ROA | (40.6%) | (13.7%) | 14% |
|
| ROE | 184.6% | (15.9%) | 98% |
|
| Liabilities to Assets | 39.1% | 44.9% | 29% |
|
| F-Score | 2 | 4 | na |
|
INVO Fertility, Inc. did not pass any screens on 7/30/2026.
